The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumResearch - Trillium (TRIL), a name many readers have expressed interest in, announced two material pieces of news yesterday afternoon. Results from latest Cohort for TTI-622 monotherapy … Continue Reading
PremiumInsights - Merck announced data for their Phase 3 cough program this morning and it was rather disappointing. Cough effect in Phase 3 saw a large decrease from Phase … Continue Reading
Read nowInsights - Aerpio (ARPO) is developing a novel treatment for glaucoma that has Phase 2 data by the end of 2020. The company’s drug, razuprotafib, has shown to … Continue Reading
PremiumInsights - Affimed (AFMD) announced Q2 results today, which showed that the pipeline is progressing as planned. Below is an update for each candidate: AFM13: On Track … Continue Reading
Read nowInsights - Fennec announced that the FDA issued a CRL for Pedmark, citing manufacturing issues. The FDA did not identify any clinical safety or efficacy issues, so … Continue Reading
PremiumInsights - Today La Jolla (LJPC) announced Q2 results for Giapreza and numbers were very underwhelming. For the three months ended June 30, 2020, U.S. sales of Giapreza were $5.8 … Continue Reading
PremiumInsights - Fennec filed a trademark for their “PEDMARK” drug today. This is a good sign as Fennec is preparing for commercialization (and therefore FDA approval) of Pedmark. Fennec’s … Continue Reading
Premium
